PXMD Stock - PaxMedica, Inc. Common Stock
Unlock GoAI Insights for PXMD
Get institutional-grade AI analysis, real-time signals, and deep market intelligence powered by advanced machine learning.
Free 14-day trial • No credit card required
Premium members get real-time SMS alerts
Financial Statements
| Metric | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|
| Revenue | N/A | N/A | N/A | N/A | N/A |
| Gross Profit | N/A | N/A | N/A | N/A | N/A |
| Gross Margin | N/A | N/A | N/A | N/A | N/A |
| Operating Income | $-16,145,000 | $-10,604,000 | $-7,198,000 | $-5,566,000 | $-599,000 |
| Net Income | $-18,290,000 | $-14,802,000 | $-13,035,000 | $-8,489,000 | $-599,000 |
| Net Margin | N/A | N/A | N/A | N/A | N/A |
| EPS | $-11.00 | $-28.73 | $-18.81 | $-13.42 | $-0.06 |
PaxMedica, Inc., a clinical stage biopharmaceutical company, focuses on the development of anti-purinergic drug therapies (APT) for the treatment of disorders with intractable neurologic symptoms. The company's lead product candidate is PAX-101, an intravenous formulation of suramin for various indications, including autism spectrum disorder, myalgic encephalomyelitis/chronic fatigue syndrome, long COVID-19 syndrome, and human african trypanosomiasis. It is also involved in developing PAX-102, an intranasal formulation of suramin for neurologic indications. The company was formerly known as Purinix Pharmaceuticals LLC and changed its name to PaxMedica, Inc. in April 2020. PaxMedica, Inc. was incorporated in 2018 and is based in Tarrytown, New York. PaxMedica, Inc. operates as a subsidiary of Tardimed Sciences LLC.
Visit WebsiteEarnings History & Surprises
PXMDEPS Surprise History
Quarterly EPS Details
| Period | Report Date | Estimated EPS | Actual EPS | Surprise | Result |
|---|---|---|---|---|---|
Q3 2024 | Sep 20, 2024 | — | $-0.39 | — | — |
Q2 2024 | May 13, 2024 | $-0.43 | $-0.50 | -16.3% | ✗ MISS |
Q2 2024 | Apr 3, 2024 | $-0.88 | $-1.45 | -64.8% | ✗ MISS |
Q4 2023 | Nov 15, 2023 | — | $-5.20 | — | — |
Q3 2023 | Aug 9, 2023 | — | $-4.08 | — | — |
Q2 2023 | May 15, 2023 | — | $-5.10 | — | — |
Q1 2023 | Mar 29, 2023 | — | $-0.59 | — | — |
Q4 2022 | Nov 15, 2022 | — | $-14.80 | — | — |
Q3 2022 | Sep 30, 2022 | — | $0.00 | — | — |
Q1 2022 | Mar 31, 2022 | — | $0.19 | — | — |
Q4 2021 | Dec 31, 2021 | — | $0.62 | — | — |
Q3 2021 | Sep 30, 2021 | — | $-0.31 | — | — |
Q2 2021 | Jun 30, 2021 | — | $-0.61 | — | — |
Q1 2021 | Mar 31, 2021 | — | $-0.72 | — | — |
Q4 2020 | Dec 31, 2020 | — | $-0.44 | — | — |
Q3 2020 | Sep 30, 2020 | — | $-0.22 | — | — |
Q2 2020 | Jun 30, 2020 | — | $-0.21 | — | — |
Q1 2020 | Mar 31, 2020 | — | $-0.03 | — | — |
Q2 2019 | Jun 30, 2019 | — | $-0.01 | — | — |
Q1 2019 | Mar 31, 2019 | — | $-0.01 | — | — |
Latest News
Frequently Asked Questions about PXMD
What is PXMD's current stock price?
What is the analyst price target for PXMD?
What sector is PaxMedica, Inc. Common Stock in?
What is PXMD's market cap?
Does PXMD pay dividends?
Similar Stocks
Healthcare SectorExplore stocks similar to PXMD for comparison